Published in Int J Cardiol on November 26, 2010
Left atrial appendage occlusion in valvular atrial fibrillation following MitraClip implantation. Clin Res Cardiol (2012) 0.82
Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation. BMC Cardiovasc Disord (2016) 0.75
Roles of real-time three-dimensional transesophageal echocardiography in peri-operation of transcatheter left atrial appendage closure. Medicine (Baltimore) (2017) 0.75
Updates on new oral anticoagulants and percutaneous devices for stroke prevention in patients with non-valvular atrial fibrillation. Int J Cardiol (2012) 0.75
Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol (2009) 3.18
Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery? JACC Cardiovasc Interv (2009) 1.61
May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke (2009) 1.58
Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. JACC Cardiovasc Interv (2009) 1.52
Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: analysis of the Melbourne Interventional Group registry. Eur J Heart Fail (2011) 1.41
Unusual case of recurrent renal artery stenosis: lessons to learn. Kidney Int (2008) 1.40
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol (2010) 1.39
Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug Discov Today (2010) 1.24
Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv (2011) 1.20
Left atrial appendage exclusion: state-of-the-art. Catheter Cardiovasc Interv (2010) 1.12
Subjects at risk of discontinuation of lipid-lowering agents: a 6-month cohort study among 12,875 patients in a chinese population. Clin Ther (2011) 1.10
Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail (2011) 1.07
Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre™ device) in a canine model. Int J Cardiol (2013) 0.97
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. Am Heart J (2009) 0.96
Role of warfarin pharmacogenetic testing in clinical practice. Pharmacogenomics (2010) 0.92
Images in cardiovascular medicine. Giant left circumflex coronary artery aneurysm with arteriovenous fistula to the coronary sinus. Circulation (2008) 0.90
Venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol (2013) 0.90
The mystery of coronary artery spasm. Heart Lung Circ (2006) 0.87
Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions? Br J Clin Pharmacol (2011) 0.87
Coil embolization of an iatrogenic coronary artery to cardiac vein fistula after rotational atherectomy. J Interv Cardiol (2008) 0.86
Marantic endocarditis presenting as recurrent arterial embolisation. Int J Cardiol (2007) 0.86
Measuring health related quality of life in coronary heart disease: the importance of feeling well. Int J Cardiol (2010) 0.86
Quality of life after percutaneous coronary intervention in the elderly with acute coronary syndrome. Int J Cardiol (2010) 0.85
Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm. Cardiovasc Hematol Agents Med Chem (2009) 0.85
Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease. Clin Cardiol (2013) 0.84
Endoscopy for upper gastrointestinal bleeding: how urgent is it? Nat Rev Gastroenterol Hepatol (2009) 0.84
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes. Int J Cardiol (2010) 0.84
Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling. Cardiovasc Res (2013) 0.83
The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome. Clin Cardiol (2011) 0.83
An armband wearable device for overnight and cuff-less blood pressure measurement. IEEE Trans Biomed Eng (2014) 0.82
Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: experience in Hong Kong. Clin Cardiol (2012) 0.82
Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data. Pharmacol Ther (2010) 0.82
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry. Med J Aust (2008) 0.81
Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension. PLoS One (2013) 0.81
Attenuation of systolic blood pressure and pulse transit time hysteresis during exercise and recovery in cardiovascular patients. IEEE Trans Biomed Eng (2014) 0.80
Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited. Int J Cardiol (2012) 0.80
Bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials. Cardiovasc Drugs Ther (2013) 0.80
Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel. Pharmacol Ther (2009) 0.80
Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting. Cardiovasc Hematol Agents Med Chem (2008) 0.80
Management of access site and systemic complications of percutaneous coronary and peripheral interventions. J Invasive Cardiol (2008) 0.79
Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention. Cardiovasc Revasc Med (2009) 0.79
Investigational devices for mitral regurgitation: state of the art. Expert Rev Med Devices (2011) 0.79
Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong. Clin Cardiol (2012) 0.79
Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting. J Gastroenterol Hepatol (2010) 0.79
The clinical outcome of restricting drug-eluting stents to patients at highest risk of restenosis. EuroIntervention (2006) 0.79
Renal artery revascularization: collaborative approaches for specialists. Adv Chronic Kidney Dis (2008) 0.78
Correlates of carotid stenosis in patients undergoing coronary artery bypass grafting--a case control study. Vasc Med (2009) 0.78
Wearable cuff-less PTT-based system for overnight blood pressure monitoring. Conf Proc IEEE Eng Med Biol Soc (2013) 0.78
Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome. Cardiovasc Ther (2011) 0.77
Cardiovascular medication use following percutaneous coronary intervention: the Australian experience. Cardiovasc Ther (2014) 0.77
Enhanced detection of patent foramen ovale by systematic transthoracic saline contrast echocardiography. Int J Cardiol (2010) 0.77
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation--a real patient data analysis in a Hong Kong teaching hospital. Clin Cardiol (2013) 0.77
The no-reflow phenomenon in the coronary circulation. Cardiovasc Hematol Agents Med Chem (2009) 0.77
Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents. Heart Lung Circ (2007) 0.76
Treatment of renal artery in-stent restenosis with sirolimus-eluting stents. Vasc Med (2009) 0.76
Isolated heart models for studying cardiac electrophysiology: a historical perspective and recent advances. J Basic Clin Physiol Pharmacol (2017) 0.75
Antiplatelet therapy for the primary and secondary prevention of cerebrovascular events in patients with extracranial carotid artery disease. J Vasc Surg (2009) 0.75
Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome. Expert Opin Drug Metab Toxicol (2012) 0.75
Protection devices and thrombectomy for native coronary artery ST-elevation myocardial infarction. J Invasive Cardiol (2008) 0.75
What's Old is New Again - A review of the current evidence of colchicine in cardiovascular medicine. Curr Cardiol Rev (2016) 0.75
Current status of pharmacological thrombolytic therapy and mechanical thrombectomy for the treatment of acute deep venous thrombosis. Cardiovasc Hematol Agents Med Chem (2009) 0.75
Noninvasive Characterization of Vascular Tone by Model-Based System Identification in Healthy and Heart Failure Patients. Ann Biomed Eng (2015) 0.75
Coherence analysis of invasive blood pressure and its noninvasive indicators for improvement of cuffless measurement accuracy. Conf Proc IEEE Eng Med Biol Soc (2017) 0.75
Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat". Tech Vasc Interv Radiol (2010) 0.75
Left atrial remodeling and reduced atrial pump function after chronic right ventricular apical pacing in patients with preserved ejection fraction. Int J Cardiol (2011) 0.75
Patient awareness of serious consequences of non-adherence to antiplatelet therapy after coronary stenting. Int J Cardiol (2012) 0.75
Images in cardiovascular medicine. Adventitial fibromuscular dysplasia of the renal artery: management challenges of nonatherosclerotic renal artery stenosis. Circulation (2009) 0.75
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registry. Int J Cardiol (2013) 0.75
Clinical manifestation and current management of patent foramen ovale. Expert Rev Cardiovasc Ther (2009) 0.75